Park Avenue Securities »

SPDR S&P Pharmaceuticals shares owned by Park Avenue Securities

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Park Avenue Securities from 13F filings

Historical chart of Park Avenue Securities investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Park Avenue Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Park Avenue Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $485k 10k 47.97

More positions owned by Park Avenue Securities

Ishares Tr Core S&p500 Etf (IVV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Core Msci Emkt (IEMG)
Ishares Tr S&p 100 Etf (OEF)
Ishares Tr 10-20 Yr Trs Etf (TLH)
NVIDIA Corporation (NVDA)
Blackrock Etf Trust Ishares A I Inno (BAI)
Blackrock Etf Trust Ishares Us Thema (THRO)
Microsoft Corporation (MSFT)
Apple (AAPL)

View all positions for Park Avenue Securities

Top funds holding SPDR S&P Pharmaceuticals

Morgan Stanley
Envestnet Asset Management
LPL Financial
First Citizens Bank & Trust
Envestnet Portfolio Solutions
Goldman Sachs Group
Susquehanna International
Wells Fargo & Company
Cetera Investment Advisers
Jpmorgan Chase & Co
CX Institutional
Wharton Business Group
Clark Capital Management Group
Bp Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding SPDR S&P Pharmaceuticals